Fig. 3.
Kaplan-Meier estimates of the distributions of RFS from day of CR, by treatment arm, based on 95 patients with centrally confirmed diagnoses of non-M3 AML who achieved CR. Tickmarks indicate censored data.
Kaplan-Meier estimates of the distributions of RFS from day of CR, by treatment arm, based on 95 patients with centrally confirmed diagnoses of non-M3 AML who achieved CR. Tickmarks indicate censored data.
